Stephen S. Yoder
2019
In 2019, Stephen S. Yoder earned a total compensation of $1.6M as Chief Executive Officer at Pieris Pharmaceuticals, a 39% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $208,575 |
|---|---|
| Option Awards | $815,670 |
| Salary | $515,000 |
| Other | $54,353 |
| Total | $1,593,598 |
Yoder received $815.7K in option awards, accounting for 51% of the total pay in 2019.
Yoder also received $208.6K in non-equity incentive plan, $515K in salary and $54.4K in other compensation.
Rankings
In 2019, Stephen S. Yoder's compensation ranked 7,035th out of 13,971 executives tracked by ExecPay. In other words, Yoder earned more than 49.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,035 out of 13,971 | 50th |
Division Services | 1,390 out of 2,393 | 42nd |
Major group Engineering, Accounting, Research, Management, And Related Services | 96 out of 179 | 46th |
Industry group Research, Development, And Testing Services | 28 out of 50 | 44th |
Industry Commercial Physical and Biological Research | 27 out of 44 | 39th |
Source: SEC filing on April 28, 2020.
Yoder's colleagues
We found two more compensation records of executives who worked with Stephen S. Yoder at Pieris Pharmaceuticals in 2019.